Schedule 13G ownership disclosure
AGEX THERAPEUTICS INC
Security class unavailable · CUSIP: 00848H108
Event date: 2020-10-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9984%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000897101-20-000805
- Form type
- SC 13G
- Filer
- Serina Therapeutics, Inc.
- CIK
- CIK 1708599
- Filed
- Oct 16, 2020
- Reporting period
- Oct 08, 2020
- Description
- Schedule 13G beneficial ownership